The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment

Giorgio Bogani, Umberto Leone Roberti Maggiore, Mauro Signorelli, Fabio Martinelli, Antonino Ditto, Ilaria Sabatucci, Lavinia Mosca, Domenica Lorusso, Francesco Raspagliesi

Research output: Contribution to journalReview article

Abstract

Human papillomavirus (HPV) is the most common sexually transmitted disease, worldwide. Primary prevention thorough vaccination si able to reduce the burden of HPV-related lesions. Ten years ago the Food and drug Administration (FDA) approved the first vaccine against HPV. In the last decades, growing data on safety and effectiveness have been collected. In the present review we report the current knowledge on vaccine against HPV, highlighting the current value and prospective regarding the widespread diffusion of HPV vaccines. The role of emerging therapeutic vaccines is reviewed.

Original languageEnglish
Pages (from-to)92-97
Number of pages6
JournalCritical Reviews in Oncology/Hematology
Volume122
DOIs
Publication statusPublished - Feb 2018

Fingerprint

Papillomavirus Vaccines
Uterine Cervical Neoplasms
United States Food and Drug Administration
Primary Prevention
Sexually Transmitted Diseases
Vaccination
Therapeutics
Vaccines
Safety

Keywords

  • Female
  • Humans
  • Papillomaviridae/immunology
  • Papillomavirus Infections/prevention & control
  • Papillomavirus Vaccines/administration & dosage
  • Prospective Studies
  • Randomized Controlled Trials as Topic
  • Uterine Cervical Neoplasms/prevention & control
  • Vaccination/statistics & numerical data

Cite this

The role of human papillomavirus vaccines in cervical cancer : Prevention and treatment. / Bogani, Giorgio; Leone Roberti Maggiore, Umberto; Signorelli, Mauro; Martinelli, Fabio; Ditto, Antonino; Sabatucci, Ilaria; Mosca, Lavinia; Lorusso, Domenica; Raspagliesi, Francesco.

In: Critical Reviews in Oncology/Hematology, Vol. 122, 02.2018, p. 92-97.

Research output: Contribution to journalReview article

@article{dc21fe5072364e24ad82d380f95064a7,
title = "The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment",
abstract = "Human papillomavirus (HPV) is the most common sexually transmitted disease, worldwide. Primary prevention thorough vaccination si able to reduce the burden of HPV-related lesions. Ten years ago the Food and drug Administration (FDA) approved the first vaccine against HPV. In the last decades, growing data on safety and effectiveness have been collected. In the present review we report the current knowledge on vaccine against HPV, highlighting the current value and prospective regarding the widespread diffusion of HPV vaccines. The role of emerging therapeutic vaccines is reviewed.",
keywords = "Female, Humans, Papillomaviridae/immunology, Papillomavirus Infections/prevention & control, Papillomavirus Vaccines/administration & dosage, Prospective Studies, Randomized Controlled Trials as Topic, Uterine Cervical Neoplasms/prevention & control, Vaccination/statistics & numerical data",
author = "Giorgio Bogani and {Leone Roberti Maggiore}, Umberto and Mauro Signorelli and Fabio Martinelli and Antonino Ditto and Ilaria Sabatucci and Lavinia Mosca and Domenica Lorusso and Francesco Raspagliesi",
note = "Copyright {\circledC} 2017 Elsevier B.V. All rights reserved.",
year = "2018",
month = "2",
doi = "10.1016/j.critrevonc.2017.12.017",
language = "English",
volume = "122",
pages = "92--97",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - The role of human papillomavirus vaccines in cervical cancer

T2 - Prevention and treatment

AU - Bogani, Giorgio

AU - Leone Roberti Maggiore, Umberto

AU - Signorelli, Mauro

AU - Martinelli, Fabio

AU - Ditto, Antonino

AU - Sabatucci, Ilaria

AU - Mosca, Lavinia

AU - Lorusso, Domenica

AU - Raspagliesi, Francesco

N1 - Copyright © 2017 Elsevier B.V. All rights reserved.

PY - 2018/2

Y1 - 2018/2

N2 - Human papillomavirus (HPV) is the most common sexually transmitted disease, worldwide. Primary prevention thorough vaccination si able to reduce the burden of HPV-related lesions. Ten years ago the Food and drug Administration (FDA) approved the first vaccine against HPV. In the last decades, growing data on safety and effectiveness have been collected. In the present review we report the current knowledge on vaccine against HPV, highlighting the current value and prospective regarding the widespread diffusion of HPV vaccines. The role of emerging therapeutic vaccines is reviewed.

AB - Human papillomavirus (HPV) is the most common sexually transmitted disease, worldwide. Primary prevention thorough vaccination si able to reduce the burden of HPV-related lesions. Ten years ago the Food and drug Administration (FDA) approved the first vaccine against HPV. In the last decades, growing data on safety and effectiveness have been collected. In the present review we report the current knowledge on vaccine against HPV, highlighting the current value and prospective regarding the widespread diffusion of HPV vaccines. The role of emerging therapeutic vaccines is reviewed.

KW - Female

KW - Humans

KW - Papillomaviridae/immunology

KW - Papillomavirus Infections/prevention & control

KW - Papillomavirus Vaccines/administration & dosage

KW - Prospective Studies

KW - Randomized Controlled Trials as Topic

KW - Uterine Cervical Neoplasms/prevention & control

KW - Vaccination/statistics & numerical data

U2 - 10.1016/j.critrevonc.2017.12.017

DO - 10.1016/j.critrevonc.2017.12.017

M3 - Review article

C2 - 29458794

VL - 122

SP - 92

EP - 97

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

ER -